DUOMO HP (2,0 + 5,0) MG COM REV CAP DURA CT BL AL PLAS PVC/PVDC TRANS X 10
Apresentação · Câmara de Regulação do Mercado de Medicamentos (CMED), Secretaria Executiva exercida pela Agência Nacional de Vigilância Sanitária (ANVISA) · Brasil
-
Número de registro
1004310760011 -
GGREM
508022010148203 -
Código de barras
7891317013691
O que a fonte publica
- Detentor do registro
- EUROFARMA LABORATORIOS S.A.
- Princípios ativos
- MESILATO DE DOXAZOSINA;FINASTERIDA
- Embalagem
- (2,0 + 5,0) MG COM REV CAP DURA CT BL AL PLAS PVC/PVDC TRANS X 10
- Regime de dispensação
- Tarja Vermelha
- Tipo de produto
- Novo
- Classe terapêutica
- G4C4 - BPH COMBINAÇÕES DE ALFA-ANTAGONISTAS E INIBIDORES DA 5-ALFA TESTOSTERONA REDUTASE
- Prescrição
- Sob prescrição ou restrito
Nomes pelos quais este registro é encontrado
- DUOMO HP (2,0 + 5,0) MG COM REV CAP DURA CT BL AL PLAS PVC/PVDC TRANS X 10
- DUOMO HP
- MESILATO DE DOXAZOSINA
- FINASTERIDA
Dados completos da fonte
{
"name": "DUOMO HP (2,0 + 5,0) MG COM REV CAP DURA CT BL AL PLAS PVC/PVDC TRANS X 10",
"holder": "EUROFARMA LABORATORIOS S.A.",
"stripe": "Tarja Vermelha",
"barcodes": [
"7891317013691"
],
"confaz87": false,
"currency": "BRL",
"marketed": null,
"ggremCode": "508022010148203",
"useDomain": "unknown",
"capApplies": null,
"icmsExempt": false,
"holderTaxId": "61.190.096/0001-92",
"priceRegime": "Regulado",
"productName": "DUOMO HP",
"productType": "Novo",
"hospitalOnly": false,
"presentation": "(2,0 + 5,0) MG COM REV CAP DURA CT BL AL PLAS PVC/PVDC TRANS X 10",
"sourceStatus": null,
"supplyRegime": "Tarja Vermelha",
"factoryPrices": {
"icms-0": "33.79",
"icms-12": "38.40",
"icms-17": "40.71",
"icms-18": "41.21",
"icms-19": "41.72",
"icms-20": "42.24",
"icms-21": "42.77",
"icms-22": "43.32",
"icms-23": "43.88",
"icms-17.5": "40.96",
"icms-19.5": "41.98",
"icms-20.5": "42.50",
"icms-22.5": "43.60",
"icms-12-alc": "34.28",
"icms-17-alc": "36.35",
"icms-18-alc": "36.79",
"icms-19-alc": "37.25",
"icms-20-alc": "37.71",
"icms-21-alc": "38.19",
"icms-22-alc": "38.68",
"icms-23-alc": "39.18",
"withoutTaxes": "30.17",
"icms-17.5-alc": "36.57",
"icms-19.5-alc": "37.48",
"icms-20.5-alc": "37.95",
"icms-22.5-alc": "38.93"
},
"pisCofinsList": "Negativa",
"substanceText": "MESILATO DE DOXAZOSINA;FINASTERIDA",
"targetSpecies": [],
"consumerPrices": {
"icms-0": "45.33",
"icms-12": "51.51",
"icms-17": "54.61",
"icms-18": "55.28",
"icms-19": "55.97",
"icms-20": "56.66",
"icms-21": "57.37",
"icms-22": "58.11",
"icms-23": "58.86",
"icms-17.5": "54.95",
"icms-19.5": "56.31",
"icms-20.5": "57.01",
"icms-22.5": "58.49",
"icms-12-alc": "47.39",
"icms-17-alc": "50.25",
"icms-18-alc": "50.86",
"icms-19-alc": "51.50",
"icms-20-alc": "52.13",
"icms-21-alc": "52.80",
"icms-22-alc": "53.47",
"icms-23-alc": "54.16",
"withoutTaxes": "41.71",
"icms-17.5-alc": "50.56",
"icms-19.5-alc": "51.81",
"icms-20.5-alc": "52.46",
"icms-22.5-alc": "53.82"
},
"invalidBarcodes": [],
"activeSubstances": [
"MESILATO DE DOXAZOSINA",
"FINASTERIDA"
],
"therapeuticClass": "G4C4 - BPH COMBINAÇÕES DE ALFA-ANTAGONISTAS E INIBIDORES DA 5-ALFA TESTOSTERONA REDUTASE",
"commercialisation": {
"year": 2025,
"marketed": false
},
"priceAnalysisNote": null,
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "br.anvisa.cmed-prices"
},
"patientEligibility": "not-assessed",
"registrationNumber": "1004310760011",
"targetSpeciesStatus": "not-reported",
"administrativeStatus": "unknown",
"prescriptionCategory": "prescription-or-restricted",
"prescriptionRequired": true,
"therapeuticClassCode": "G4C4",
"commercialDestination": null,
"registrationNumberFlag": null
}
Leia este registro a partir do seu próprio software
O mesmo registro, com todos os campos e sua procedência, está a uma requisição de distância. A chave de API é gratuita e funciona imediatamente.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=br" \
--data-urlencode "sourceId=br.anvisa.cmed-prices" \
--data-urlencode "id=br:cmed:presentations:508022010148203"